Sunday, December 10, 2017
 
 
News: Page (1) of 1 - 02/21/12 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Johnson & Johnson CEO Bil Weldon retiring in April
Johnson & Johnson CEO Bil Weldon retiring in April, after repeated consumer product recalls
By The Associated Press

NEW BRUNSWICK, New Jersey (AP) ' Johnson & Johnson's longtime CEO, Bill Weldon, is retiring this April, following an embarrassing string of product recalls that has stretched for more than 2 years, costing the health care giant hundreds of millions of dollars and consumer trust.

The maker of Band-Aids and biotech drugs says Weldon will remain chairman of the board for the time being, while ceding the chief executive post to Alex Gorsky, head of the medical device and diagnostics business.

Weldon, 63, became chief executive in 2002. He's spent his entire career at the company.



But his tenure has been tarnished since an astounding string of more than two dozen recalls of nonprescription Tylenol, Motrin, Benadryl and other drugs began in 2009. Medical devices and consumer products also have been recalled.


Page: 1


 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The U.S. Daily News - Contact Us - Advertise With Us - Privacy Guidelines